Clik here to view.
New drug squashes cancer’s last-ditch efforts to survive
A collaboration between SBP and Salk has resulted in a drug that blocks autophagy, a process used by cancer cells to fill their elevated demand for energy.
View ArticleClik here to view.
Potential drug targets could improve treatment of vascular disease in...
Researchers find that s receptor called LRP6 inhibits diet-induced hardening of the arteries, and seek drugs that can mimic its actions.
View ArticleClik here to view.
SBP Graduate School of Biomedical Sciences receives WASC accreditation
SBP's Graduate School of Biomedical Sciences has received WASC accreditation, recognizing excellence in academic and technical training in the fields of biology, chemistry, bioinformatics, and...
View ArticleClik here to view.
Researchers find new method to halt the advance of liver cancer
Liver cancer is the third leading cause of cancer-related deaths worldwide. New research indicates that blocking the activity of the lymphotoxin-beta receptor may improve the outcome of for patients...
View ArticleClik here to view.
Pathway that controls cancer cell proliferation discovered
Study reveals new drug targets to selectively inhibit a key event in tumor-cell progression.
View ArticleClik here to view.
10 years of studying the metabolism, nutrition, and human energy—what have we...
What have scientists learned about the metabolism in the past decade?
View ArticleClik here to view.
SBP surfers rule!
Did you know that SBP has a surfing team? Not only do we have a team, but we have a winning team! Last weekend, Carl Ware, full-time immunologist and part-time surfer, led the SBP team to victory in...
View ArticleClik here to view.
Explaining your science
Come learn to effectively explain your research to non-scientists.
View ArticleClik here to view.
The Mayor of San Diego visits SBP in La Jolla
Mayor Kevin Faulconer visits Sanford Burnham Prebys Medical Discovery Institute.
View ArticleClik here to view.
Postdoc Symposium 2015
SBP held an inaugural Postdoc Symposium to showcase the critical contributions made by 126 SBP postdoctoral students.
View ArticleClik here to view.
Pedal the Cause: Team SBP pedals for Luke
Luke Sybert is a cancer patient at Rady Children's Hospital. Team SBP is riding for Luke in the 2015 Pedal the Cause event.
View ArticleClik here to view.
Meet the “drug hunter”
Al-Hajj’s goal is to establish a reason to believe our scientific discoveries merit investment in the expensive process of drug discovery.
View ArticleClik here to view.
New STRIVE Awards Announced
“The STRIVE award is providing funds that allow us to accelerate the testing of a new hypothesis that connects the microbiome, epigenetics, and colorectal cancer.” --Alex Strongin, Ph.D. professor in...
View ArticleClik here to view.
A day in the life of a cancer researcher
Petrus De Jong, M.D., Ph.D. is a cancer researcher at SBP in the lab of Dr. Garth Powis.
View ArticleClik here to view.
The Collaboration 4 Cure Alzheimer’s research awards announced at SBP
On October 28, Mayor Kevin Faulconer, County Supervisor Diane Jacob, San Diego philanthropist Darlene Shiley, and Mary Ball, president and CEO of the Alzheimer’s Association San Diego, came to SBP to...
View ArticleClik here to view.
The Diabetes Story: Will new treatments lead to novel weight loss drugs?
Is diabetes research leading to new weight loss drugs?
View ArticleClik here to view.
Leading cardiometabolic researcher to join SBP
Leading cardiometabolic researcher to join SBP.
View ArticleClik here to view.
Antioxidant-rich diet could help stave off type 2 diabetes
Type 2 diabetes affects about 8% of all adults and is a leading cause of death worldwide.
View ArticleClik here to view.
Can your heart prevent diabetes?
Increasing a person’s brown fat could improve the risks associated with obesity.
View ArticleClik here to view.
Scientists identify promising new melanoma drug
A new drug may help melanoma patients overcome drug resistance to current therapy.
View Article